About 1,293 results

ALLMedicine™ Anovulation Center

Research & Reviews  397 results

Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's ...
Reproductive Health; Sarahian N, Sarvazad H et. al.

Jul 28th, 2021 - The most common endocrine and metabolic disorders in premenopausal women is polycystic ovary syndrome (PCOS), characterized by hyperandrogenism, chronic anovulation, and/or ultrasound evidence of small ovarian cysts. Obesity and insulin resistance...

Cardiometabolic consequences of maternal hyperandrogenemia in male offspring.
Physiological Reports; Zuchowski Y, Dalmasso C et. al.

Jul 22nd, 2021 - Polycystic ovary syndrome (PCOS) in women is characterized by hyperandrogenemia, obesity, and oligo- or anovulation. In addition, women with PCOS are often obese, with insulin resistance, hyperlipidemia, and elevated blood pressure. The cardiometa...

The Disorders of Endometrial Receptivity in PCOS and Its Mechanisms.
https://doi.org/10.1007/s43032-021-00629-9 10.1093/humrep/dew218 10.5694/j.1326-5377.1991.tb93959.x 10.1093/oxfordjournals.humrep.a138174 10.1016/S0015-0282(16)57793-0 10.1056/NEJM199906103402304 10.1530/REP-19-0402 10.1016/j.fertnstert.2019.02.029 10.21037/atm-20-5463 10.1093/hropen/hox031 10.1016/j.fertnstert.2010.04.063 10.1016/j.fertnstert.2012.09.046 10.1007/s10815-020-01948-7 10.1093/humupd/dmy044 10.1590/S0104-42302011000600020 10.1177/1933719113519169 10.1073/pnas.88.24.11408 10.1210/endo.141.12.7855 10.1095/biolreprod.102.014969 10.1093/humrep/del093 10.17576/jsm-2018-4710-28 10.1177/1933719116648216 10.1002/jcp.24241 10.1002/jcp.26852 10.1016/j.bbrc.2015.12.103 10.1016/S1472-6483(10)60228-3 10.1002/ijgo.12898 10.3109/09513590.2014.989980 10.1007/s00441-020-03171-3 10.1016/j.rbmo.2018.04.043 10.1007/s00109-020-01985-w 10.2147/TACG.S207491 10.1186/s13048-017-0308-5 10.4103/GMIT.GMIT_112_18 10.1016/j.rbmo.2017.12.020 10.1093/biolre/ioy187 10.1210/me.2013-1206 10.1074/jbc.M114.588897 10.3892/mmr.2016.5142 10.1210/jc.2002-021072 10.1007/s10815-013-0088-9 10.1002/dvdy.1209 10.1007/s43032-019-00072-x 10.1095/biolreprod66.2.297 10.1016/j.fertnstert.2005.09.053 10.1016/j.rbmo.2019.03.211 10.1080/09513590.2020.1727433 10.1177/1933719113519169 10.1210/jcem.86.12.8088 10.1210/jc.2014-2569 10.1016/j.steroids.2011.12.017 10.1210/edrv-11-1-80 10.1530/REP-15-0044 10.1186/s13048-015-0139-1 10.1210/clinem/dgaa060 10.1016/j.mce.2016.11.009 10.1007/s43032-020-00194-7 10.1097/PAP.0b013e318234aaed 10.1210/jc.2011-2366 10.1007/s00109-019-01809-6 10.1159/000486784 10.18632/oncotarget.24821 10.21873/invivo.11764 10.21873/invivo.11981 10.1152/ajpendo.00359.2018 10.1186/s13048-017-0359-7 10.1189/jlb.0708395 10.1530/REP-12-0217 10.1111/j.1600-0897.2009.00792.x 10.1210/en.2017-00495 10.1093/humrep/dev055 10.1016/j.ando.2019.10.002 10.1111/aji.13170 10.1177/1933719116653681 10.1155/2009/465203 10.3109/09513590.2012.760195 10.1177/1179558119861936 10.1093/biolre/ioz180 10.1007/s12020-019-01972-3 10.1093/molehr/gap030 10.1038/ejcn.2012.220 10.1016/j.lfs.2020.117830 10.1016/j.lfs.2020.117344 10.1111/j.1476-5381.2009.00450.x 10.1016/j.metabol.2015.08.010 10.1186/s12986-018-0306-7 10.1096/fj.08-109033 10.1080/09513590.2019.1633297 10.1093/humrep/dey029 10.1210/er.2011-1034 10.1038/414799a 10.1210/jc.2017-02459 10.1111/cen.12099 10.1111/cen.13808 10.1016/j.mce.2018.05.010 10.1177/1933719117732157 10.1016/j.steroids.2011.12.003 10.1007/s43032-019-00026-3 10.1177/1535370215584937 10.2478/jomb-2018-0008 10.1016/j.fertnstert.2011.03.021 10.1016/j.fertnstert.2016.11.009 10.1016/j.fertnstert.2016.07.1069 10.2174/13816128112092482 10.1097/gme.0b013e3181e170af 10.1186/s12958-017-0227-8 10.1210/er.2015-1104 10.1016/j.metabol.2018.11.002 10.1093/humrep/deu114 10.1016/j.cyto.2019.04.006 10.3109/09513590.2014.951321 10.1177/1933719118820466 10.1159/000491086 10.1007/s00404-017-4295-y 10.1371/journal.pone.0217095 10.1530/REP-18-0518 10.1152/ajpendo.00162.2019 10.1007/s00125-016-4053-x 10.1210/en.2017-03082 10.1056/NEJM198807283190401 10.2337/diab.38.9.1165 10.1080/13813455.2018.1499120 10.1038/ijo.2016.154
Reproductive Sciences (Thousand Oaks, Calif.); Jiang NX, Li XL

May 29th, 2021 - Polycystic ovary syndrome (PCOS) is a mysterious and complicated endocrine disease with the combination of metabolic, reproductive, psychological dysfunctions. Impaired endometrial receptivity and ovulation disorders/anovulation are both important...

see more →

Guidelines  1 results

Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline.
The Journal of Clinical Endocrinology and Metabolism; Gordon CM, Ackerman KE et. al.

Apr 4th, 2017 - The American Society for Reproductive Medicine, the European Society of Endocrinology, and the Pediatric Endocrine Society. This guideline was funded by the Endocrine Society. To formulate clinical practice guidelines for the diagnosis and treatme...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  44 results

Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant

Mar 18th, 2020 - Introduction: PCOS is the most common cause of anovulatory infertility which affects 12-21% of the population. This percentage may vary according to the criteria used and population studied.Hyperandrogenism, chronic anovulation, and occasionally o...

Effectiveness and Safety of Bushen Culuan Decoction for Anovulatory Infertility

Jan 10th, 2019 - Anovulation is one of the main causes of female infertility. Anovulatory infertility account for a proportion of 25-30% in whole female infertility. In western medicine, hormone induced ovulation and assisted reproduction technology are two main w...

Hysteroscopy in Chronic Anovulation

Sep 26th, 2018 - Patients with chronic anovulation presenting to the IVF clinic for subfertility treatment are at increased risk of endometrial hyperplasia and carcinoma.They are often subjected to endometrial biopsy to rule out any underlying changes such as endo...

Visanne Post-approval Observational Study (VIPOS)

Aug 10th, 2018 - Endometriosis is a common, chronic, gynecological disease characterized by pain and impaired fertility. It causes chronic inflammation, ovarian cyst formation, fibrosis and adhesions. Symptoms seem to respond to decreased circulating estrogen. The...

Androgen Responses to hCG and Ovarian Morphology in PCOS

Aug 9th, 2018 - 50-100 PCOS and 50-100 normal women matched for age (<37 yr) and BMI (<35) will be studied. PCOS and normal women in the mid-follicular phase (day 5-7) of the menstrual cycle will receive an iv injection of hCG as previously described (see Experim...

see more →

News  71 results

No Increase in Breast Cancer Risk With Fertility Treatments

Jun 29th, 2021 - No link between fertility treatment and an increase in the risk for breast cancer was found in the largest study of the issue to date. This study "provides the evidence needed to reassure women and couples seeking fertility treatments," commented ...

Women With PCOS at Increased Risk for COVID-19

Mar 18th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Women with polycystic ovary syndrome (PCOS) face an almost 30% increased risk for COVID-19 compared with unaffected women, even after adjusting fo...

ACOG advises bleeding disorder screening for teens with heavy menstruation
Heidi Splete

Aug 27th, 2019 - Adolescent girls with heavy menstrual bleeding should be assessed for bleeding disorders, according to a Committee Opinion issued by the American College of Obstetricians and Gynecologists. A bleeding disorder is secondary only to anovulation as a.

Obesity and Infertility: The Impact of BMI on the Outcomes of IVF

Feb 14th, 2019 - Link Between Body Weight and Fertility The prevalence of obesity has tripled since 1975, and in 2016 it was estimated that 1.9 billion adults worldwide were overweight or obese.[1] On the basis of 2013-2014 data, 66.9% of US women were overweight ...

Medical Treatment of Fibroids and Related Heavy Menstrual Bleeding

Nov 19th, 2018 - Uterine Fibroids and Heavy Menstrual Bleeding A typical menstruation occurs every 21-35 days (typically around 28 days) and lasts for 2-7 days. Excessive bleeding (heavy flow, clots) or menstruation that lasts longer than 7 days could cause anemia...

see more →

Patient Education  1 results see all →